Rediscovering an old friend, IFG-I: Potential use in the treatment of neurodegenerative diseases

Trends in Neurosciences

Volumn 20, Issue 8, 1997, Pages 326-331

  Doré, Sylvain ^a   Satyabrata, Kar ^a   Quirion, Remi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN PROTECTION; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG MECHANISM; GROWTH RETARDATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0343765729     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(96)01036-3     Document Type: Note

References (64)

1. Lindsay, R.M. et al. (1994) Trends Neurosci. 17, 182-194
2. Yuen, E.C. and Mobley, W.C. (1996) Ann. Neurol. 40, 346-354
3. de Pablo, F. and de la Rosa, E.J. (1995) Trends Neurosci. 18, 143-150
4. LeRoith, D. et al. (1995) Endocr. Rev. 16, 143-163
5. Murphy, M.F. et al. (1995) Am. Neurol. Assoc. Abstr. 38, 335
6. Jones, J.I. and Clemmons, D.R. (1995) Endocr. Rev. 16, 3-34
7. De Meyts, P. et al. (1994) Horm. Res. 42, 152-169
8. Festoff, B.W. (1996) Drugs 52, 28-44
9. Rosen, D.R. et al. (1993) Nature 362, 59-62
10. Bähr, M. and Bonhoeffer, F. (1994) Trends Neurosci. 17, 473-479
11. Lewis, M.E. et al. (1993) Exp. Neurol. 124, 73-88
12. Ishii, D.N., Glazner, G.W. and Pu, S-F. (1994) Pharmacol. Ther. 62, 125-144
13. Adem, A. et al. (1994) J. Neural Transm. 97, 73-84
14. Doré, S. et al. (1996) Mol. Brain Res. 41, 128-133
15. Kanje, M. et al. (1991) Brain Res. 563, 285-287
16. Hantai, D. et al. (1995) J. Neurol. Sci. 129 (Suppl.), 122-126
17. Robinovinsky, E.D. et al. (1996) Soc. Neurosci. Abstr. 22, 1960
18. Thonen, H., Hughes, R.A. and Sendtner, M. (1993) Exp. Neurol. 124, 47-55
19. McMorris, F.A. and McKinnon, R.D. (1996) Brain Pathol. 6, 313-329
20. Liu, X. et al. (1994) Mol. Cell. Neurosci. 5, 418-430
21. Vlachopapapoulou, E. et al. (1995) J. Clin. Endocrinol. Metab. 80, 3715-3523
22. Shetty, K.R. et al. (1995) Ann. New York Acad. Sci. 753, 276-284
23. Rao, U. et al. (1993) J. Am. Geriatr. Soc. 41, 697-702
24. Ishii, D.N. (1995) Brain Res. Rev. 20, 47-67
25. Zhang, W., Lee, W.H. and Triarhou L.C. (1996) Nat. Med. 2, 65-71
26. Ishii, D.N., Guertin, D.M. and Whalen, L.R. (1994) Diabetologia 37, 1073-1081
27. Zhuang, H.X. et al. (1996) Exp. Neurol. 140, 198-205
28. Crosby, S.R. et al. (1992) Diabetologia 35, 868-872
29. Selkoe, D. (1994) Annu. Rev. Neurosci. 17, 489-517
30. Yankner, B.A. (1996) Neurone 16, 921-932
31. Bartus, R.T. et al. (1982) Science 217, 408-417
32. Quirion, R. (1993) J. Psychiatry Neurosci. 18, 226-234
33. Winkler, J. et al. (1995) Nature 375, 484-487
34. Hefti, F., Hartikka, J. and Knusel, B. (1989) Neurobiol. Aging 10, 515-533
35. Olson, L. (1993) Exp. Neurol. 124, 5-15
36. Konishi, Y. et al. (1994) Brain Res. 649, 53-61
37. Kar, S. et al. (1994) Soc. Neurosci. Abstr. 20, 81
38. Kar, S. et al.(1993) Neuroscience 55, 69-80
39. Guthrie, K.M., Nguyen, T. and Gall, C.M. (1995) J. Comp. Neurol. 352, 147-160
40. Park, G.H. and Buetow, D.E. (1991) Gerontology 37, 310-316
41. Stenvers, K.L., Lund, P.K. and Gallagher, M. (1996) Neuroscience 72, 505-518
42. Doré, S. et al. (1997) Neuroscience 78, 373-383
43. Crews, F.T. et al. (1992) J. Neurochem. 58, 1205-1210
44. Mooney, M. et al. (1996) Soc. Neurosci. Abstr. 22, 1237
45. Bando, H. et al. (1991) Acta Endocrinol 124, 31-36
46. Doré, S., Kar, S. and Quirion, R. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 4772-4777
47. Yankner, B.A., Caceres, A. and Duffy, L.K. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 9020-9023
48. Mattson, M.P. et al. (1993) Trends Neurosci. 16, 409-414
49. Lapchak, P.A., Araujo, D.M. and Hefti, F. (1994) Neuroscience 60, 293-298
50. Liberini, P. et al. (1994) Brain Res. 648, 1-8
51. Hsiao, K. et al. (1996) Science 274, 99-102
52. Games, D. et al. (1995) Nature 373, 523-527
53. Lee, W-H., Clemens, J.A. and Bondy, C.A. (1992) Mol. Cell. Neurosci. 3, 36-43
54. Beilharz, E.J. et al. (1995) Mol Brain Res. 29, 81-91
55. Sandberg-Wordqvist, A-C. et al. (1996) Mol. Brain Res. 38, 285-293
56. Pulsinelli, W.A., Jacewicz, M. and Buchan, A.M. (1992) in Principles of Drug Therapy in Neurology (Johnston, M.V., Macdonald, R.L. and Young, A.B., eds), pp. 118-160, F.A. Davis
57. Gluckman, P. et al. (1992) Biochem. Biophys. Res. Commun. 182, 593-599
58. Guan, J. et al. (1993) J. Cereb. Blood Flow Metab. 13, 609-616
59. Zhu, C.A. and Auer, R.N. (1994) J. Cereb. Blood Flow Metab. 14, 237-242
60. Johnston, B.M. et al. (1996) J. Clin. Invest. 97, 300-308
61. D'Mello, S.R., Soltoff, S.P. and Borodezt, K. (1996) Soc. Neurosci. Abstr. 22, 563
62. Shindler, K.S. and Roth, K.A. (1996) Soc. Neurosci. Abstr. 22, 570
63. Baserga, R. (1995) Cancer Res. 55, 249-252
64. Doré, S., Kar, S. and Quirion, R. (1997) Medicine/Sciences 13, 557-565